NCT06569602View on ClinicalTrials.gov

Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

September 30, 2030

Study Completion Date

September 30, 2033

Conditions
Tricuspid Valve RegurgitationHeart Valve DiseasesCardiovascular Diseases
Interventions
DEVICE

Transcatheter Tricuspid Valve Replacement

Replacement of the tricuspid valve through a transcatheter approach

Trial Locations (2)

Unknown

RECRUITING

Herz-und Diabeteszentrum NRW, Bad Oeynhausen

NOT_YET_RECRUITING

Inselspital, Bern

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY